Biotech Executive Brief — November 15, 2026
From Daily Biotech Executive Brief · 7:38
Show by Sturnbridge Technology Consulting
This weekend’s Biotech Executive Brief covers OpenAI’s ChatGPT Wallet, Anthropic’s IPO outlook, AI cybersecurity policy, Summit Therapeutics’ FDA setback, Regeneron’s POTS data, AstraZeneca’s bladder cancer approval, biotech financing, European market flows and U.S. aviation infrastructure disruptions. Subscribe for concise, fact-based coverage of AI, pharma, life sciences and major business developments. Presented by Sturnbridge Technology Consulting. Learn more at sturnbridgeTC.com. #Biotech #Pharma #LifeSciences #ArtificialIntelligence #BusinessNews #DigitalTransformation
More episodes of Daily Biotech Executive Brief
More episodes
- Biotech Executive Brief — November 16, 2026
- Biotech Executive Brief — November 12, 2026
- Biotech Executive Brief: August 19 2026
- Biotech Executive Brief: Thursday August 20th 2026
- Friday Aug 21 - Aug 23: Weekend Wrap-Up
- Monday August 24 2026
- Tuesday, August 25 2026
- Wednesday, August 26 2026
- Thursday, August 27th 2026
- Friday, August 28th 2026
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.